388 related articles for article (PubMed ID: 10603388)
1. Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.
Hoft DF; Schnapp AR; Eickhoff CS; Roodman ST
Infect Immun; 2000 Jan; 68(1):197-204. PubMed ID: 10603388
[TBL] [Abstract][Full Text] [Related]
2. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
3. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
4. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.
Hoft DF; Eickhoff CS
Infect Immun; 2002 Dec; 70(12):6715-25. PubMed ID: 12438346
[TBL] [Abstract][Full Text] [Related]
5. Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice.
Kumar S; Tarleton RL
J Immunol; 2001 Apr; 166(7):4596-603. PubMed ID: 11254717
[TBL] [Abstract][Full Text] [Related]
6. Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice.
Bryan MA; Guyach SE; Norris KA
PLoS Negl Trop Dis; 2010 Jul; 4(7):e733. PubMed ID: 20625554
[TBL] [Abstract][Full Text] [Related]
7. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism.
Rodrigues MM; Ribeirão M; Boscardin SB
Immunol Lett; 2000 Jul; 73(1):43-50. PubMed ID: 10963810
[TBL] [Abstract][Full Text] [Related]
8. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.
Sullivan NL; Eickhoff CS; Sagartz J; Hoft DF
J Immunol; 2015 Feb; 194(4):1806-18. PubMed ID: 25595788
[TBL] [Abstract][Full Text] [Related]
10. Expression and role of heat-shock protein 65 (HSP65) in macrophages during Trypanosoma cruzi infection: involvement of HSP65 in prevention of apoptosis of macrophages.
Sakai T; Hisaeda H; Ishikawa H; Maekawa Y; Zhang M; Nakao Y; Takeuchi T; Matsumoto K; Good RA; Himeno K
Microbes Infect; 1999 May; 1(6):419-27. PubMed ID: 10602674
[TBL] [Abstract][Full Text] [Related]
11. Role of Aryl Hydrocarbon Receptor (AhR) in the Regulation of Immunity and Immunopathology During
Ambrosio LF; Insfran C; Volpini X; Acosta Rodriguez E; Serra HM; Quintana FJ; Cervi L; Motrán CC
Front Immunol; 2019; 10():631. PubMed ID: 30984194
[TBL] [Abstract][Full Text] [Related]
12. Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi.
Cai CW; Blase JR; Zhang X; Eickhoff CS; Hoft DF
PLoS Pathog; 2016 Oct; 12(10):e1005902. PubMed ID: 27695083
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
[TBL] [Abstract][Full Text] [Related]
14.
Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
Front Immunol; 2019; 10():1456. PubMed ID: 31293599
[No Abstract] [Full Text] [Related]
15. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.
Mussalem JS; Vasconcelos JR; Squaiella CC; Ananias RZ; Braga EG; Rodrigues MM; Longo-Maugéri IM
Microbiol Immunol; 2006; 50(4):253-63. PubMed ID: 16625047
[TBL] [Abstract][Full Text] [Related]
16. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
Miller MJ; Wrightsman RA; Stryker GA; Manning JE
J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
[TBL] [Abstract][Full Text] [Related]
17. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
18. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
[TBL] [Abstract][Full Text] [Related]
19. Th17 Cells Provide Mucosal Protection against Gastric Trypanosoma cruzi Infection.
Cai CW; Eickhoff CS; Meza KA; Blase JR; Audette RE; Chan DH; Bockerstett KA; DiPaolo RJ; Hoft DF
Infect Immun; 2021 Jun; 89(7):e0073820. PubMed ID: 33941576
[TBL] [Abstract][Full Text] [Related]
20. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene.
Rodrigues MM; Ribeirão M; Pereira-Chioccola V; Renia L; Costa F
Infect Immun; 1999 Aug; 67(8):3855-63. PubMed ID: 10417149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
